• Neuromedin S (rat): Technical Guide for GPCR Signaling Assay

  2026-05-07

  Neuromedin S (rat) enables precise activation of neuromedin U receptor signaling in rat-based GPCR/G protein research, supporting investigations into energy homeostasis regulation and stress response. This product is not suitable for diagnostic or therapeutic use and requires strict adherence to solubility and storage protocols to maintain assay reproducibility.

• Prochlorperazine: Dopamine D2 Receptor Antagonist in Cancer

  2026-05-07

  Prochlorperazine, a dopamine D2 receptor antagonist, is emerging as a versatile tool in cancer and antiviral research, beyond its established antiemetic role. This article details experimental workflows, troubleshooting tips, and novel cross-domain insights, drawing from recent literature and real-world lab applications.

• Toremifene and Hormonal Therapy: Insights for Breast Cancer

  2026-05-06

  This review synthesizes two decades of data on toremifene, a selective estrogen receptor modulator, and its clinical role in hormone-sensitive breast cancer. The paper highlights the evolution of endocrine strategies, individualized medicine, and the comparative safety and efficacy of toremifene in the context of biomarker-driven cancer therapy.

• 8-Chloroadenosine: Precision Nucleoside Analog for RNA Studi

  2026-05-06

  8-Chloroadenosine offers researchers a high-purity, DMSO-soluble nucleoside analog tailored for dissecting transcriptional regulation and RNA metabolism. Its robust inhibition of RNA synthesis and proven value in cancer and apoptosis assays set it apart as the molecular biology reagent of choice for advanced experimental workflows.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor–S

  2026-05-05

  This study presents a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with stromal cell subpopulations, providing a physiologically relevant platform for preclinical oncology research. The model enhances the understanding of tumor heterogeneity, drug resistance, and supports personalized therapeutic strategies.

• Optimizing Firefly Luciferase mRNA: Mechanisms to Strategy

  2026-05-05

  Translational researchers demand robust, reproducible, and clinically relevant gene expression tools. This article dissects the mechanistic advances in Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP), contextualizes recent breakthroughs in mRNA formulation and stability, and delivers strategic guidance for maximizing translational impact. By integrating evidence from both peer-reviewed research and real-world protocols, we bridge the gap between molecular engineering and experimental success, elevating the bioluminescent reporter paradigm well beyond traditional product summaries.

• Optimized hiPSC Platelet Differentiation Shortens Time, Cuts

  2026-05-04

  This study introduces an optimized protocol for differentiating functional platelets from human induced pluripotent stem cells (hiPSCs), addressing persistent challenges of low yield and high production costs. By refining cell input, medium composition, and leveraging small molecule supplementation, the method achieves accelerated generation of functional platelets, with major implications for scalable thrombopoiesis and regenerative medicine.

• Optimizing DNA Damage Response Studies with BML-277 Chk2 Inh

  2026-05-04

  BML-277 stands out as a potent and selective Chk2 inhibitor, empowering researchers to dissect DNA damage response mechanisms and explore radioprotection of T-cells with high precision. This guide translates the latest cGAS-TRIM41 pathway insights into actionable workflows, troubleshooting advice, and protocol enhancements—bridging fundamental research with translational applications in cancer biology.

• Direct Reprogramming of Astrocytes into Motoneuron-like Cell

  2026-05-03

  This study demonstrates that a combination of four transcription factors—Ascl1, Myt1l, Pou3f2, and Isl1—can directly reprogram rat and human astrocytes into motoneuron-like cells. The findings provide mechanistic insight into cellular transitions relevant for spinal cord injury repair and highlight new avenues for regenerative neurobiology.

• Degarelix Acetate: Applied Workflows for GnRH Antagonist Res

  2026-05-02

  Degarelix acetate enables rapid, robust pituitary hormone suppression and is a gold standard for both in vitro and in vivo prostate cancer research. This guide translates the latest literature and validated protocols into actionable workflows, troubleshooting, and advanced applications for maximizing the compound’s full experimental potential.

• (+)-Bicuculline: Technical Use and Protocol Parameters

  2026-05-02

  (+)-Bicuculline is a classical GABAA receptor antagonist designed for dissecting inhibitory synaptic transmission and GABAergic signaling pathways in neuroscience research. It is not suitable for diagnostic or medical use, and rigorous solubility and handling protocols are critical for experimental reliability.

• Redefining In Vitro Drug Response Metrics in Cancer Research

  2026-05-01

  Schwartz’s dissertation introduces a rigorous framework distinguishing relative viability from fractional viability in in vitro anti-cancer assays. This improved metric clarity enables researchers to better dissect drug-induced proliferation arrest versus cell death, with important implications for assay design, data interpretation, and translational cancer biology.

• SM-102 for mRNA Delivery: Applied Workflows and Troubleshoot

  2026-04-30

  SM-102, a high-purity synthetic lipid, is pivotal for formulating lipid nanoparticles that enable efficient mRNA vaccine delivery. This article translates recent machine learning-driven advances and hands-on protocol refinements into actionable guidance for biomedical researchers seeking reproducibility and performance.

• Calpain Inhibitor I, ALLN: Technical Guide for Lab Research

  2026-04-30

  Calpain Inhibitor I, ALLN (SKU A2602) is a potent, selective inhibitor for calpain and cathepsin proteases, supporting studies of apoptosis, inflammation, and ischemia-reperfusion injury. It is not for diagnostic or therapeutic use and should be applied strictly within laboratory research workflows, observing solubility and handling specifications.

• Nigericin Sodium Salt: Precision Potassium Ionophore Workflo

  2026-04-29

  Nigericin sodium salt empowers researchers with robust, reproducible control over ion gradients and cytoplasmic pH, enabling advanced studies from platelet function to toxicology. This guide demystifies experimental workflows, data-driven optimizations, and troubleshooting strategies that set APExBIO's high-purity formulation apart.

437 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page